HK1218759A1 - 異噁唑烷衍生物 - Google Patents

異噁唑烷衍生物

Info

Publication number
HK1218759A1
HK1218759A1 HK16106684.0A HK16106684A HK1218759A1 HK 1218759 A1 HK1218759 A1 HK 1218759A1 HK 16106684 A HK16106684 A HK 16106684A HK 1218759 A1 HK1218759 A1 HK 1218759A1
Authority
HK
Hong Kong
Prior art keywords
isoxazolidine derivatives
isoxazolidine
derivatives
Prior art date
Application number
HK16106684.0A
Other languages
English (en)
Inventor
‧阿曼尼
‧吉迪尼
‧佩雷托
‧沃蒂斯
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41666572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1218759(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of HK1218759A1 publication Critical patent/HK1218759A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
HK16106684.0A 2009-09-11 2012-07-11 異噁唑烷衍生物 HK1218759A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09011665 2009-09-11

Publications (1)

Publication Number Publication Date
HK1218759A1 true HK1218759A1 (zh) 2017-03-10

Family

ID=41666572

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16106684.0A HK1218759A1 (zh) 2009-09-11 2012-07-11 異噁唑烷衍生物
HK12106794.1A HK1166085A1 (zh) 2009-09-11 2012-07-11 異噁唑烷衍生物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12106794.1A HK1166085A1 (zh) 2009-09-11 2012-07-11 異噁唑烷衍生物

Country Status (28)

Country Link
US (1) US8637662B2 (zh)
EP (2) EP2475676B1 (zh)
JP (1) JP2013504524A (zh)
KR (1) KR101451486B1 (zh)
CN (2) CN105175479B (zh)
AR (2) AR078164A1 (zh)
AU (1) AU2010294598B2 (zh)
BR (1) BR112012005503B1 (zh)
CA (1) CA2773594C (zh)
CL (1) CL2012000450A1 (zh)
CO (1) CO6511204A2 (zh)
EA (1) EA025191B1 (zh)
GE (1) GEP20146135B (zh)
HK (2) HK1218759A1 (zh)
IL (1) IL218539A (zh)
JO (1) JO3760B1 (zh)
MA (1) MA33561B1 (zh)
ME (1) ME01331B (zh)
MX (1) MX2012002967A (zh)
MY (1) MY164842A (zh)
NZ (1) NZ598662A (zh)
PE (1) PE20120894A1 (zh)
SG (2) SG10201608490VA (zh)
TN (1) TN2012000077A1 (zh)
TW (1) TWI494318B (zh)
UA (1) UA108858C2 (zh)
WO (1) WO2011029547A2 (zh)
ZA (1) ZA201201705B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201608490VA (en) * 2009-09-11 2016-11-29 Chiesi Farma Spa Isoxazolidine derivatives
TW201139369A (en) * 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
AR085817A1 (es) * 2011-03-15 2013-10-30 Chiesi Farma Spa Derivados de isoxazolidina
RU2013141933A (ru) 2011-03-15 2015-03-20 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные изоксазолидина
WO2013017374A1 (en) * 2011-08-01 2013-02-07 Chiesi Farmaceutici S.P.A. Anti -inflammatory steroids condensed in position 16,17 with pyrrolidine ring
US9155747B2 (en) * 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
HUE048020T2 (hu) 2014-05-12 2020-05-28 Verona Pharma Plc Új kezelés
EA202092492A1 (ru) 2014-09-03 2021-07-30 Ризен Фармасьютикалз Са Способ лечения и композиции, содержащие двойной ингибитор киназ pi3k дельта-гамма и кортикостероид
CN104262440B (zh) * 2014-09-10 2016-08-17 江西赣亮医药原料有限公司 一种16ɑ-羟基泼尼松龙的制备方法
CN109206471B (zh) * 2017-06-30 2022-07-12 天津药业研究院股份有限公司 一种哈西奈德的制备方法
CN109575096B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基泼尼松龙产品的新方法
CN112142820A (zh) * 2019-06-29 2020-12-29 天津药业研究院股份有限公司 曲安奈德的合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1131213B (de) * 1958-06-13 1962-06-14 Syntex Sa Verfahren zur Herstellung neuer Pregnanverbindungen
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
BR6678983D0 (pt) * 1965-05-04 1973-09-18 Merck & Co Inc Processo para preparar 21-fosfato esteroides
SE307576B (zh) * 1966-01-27 1969-01-13 Bofors Ab
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
GB1302572A (zh) * 1969-05-05 1973-01-10
SE378110B (zh) * 1972-05-19 1975-08-18 Bofors Ab
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
US4018774A (en) * 1976-02-13 1977-04-19 E. R. Squibb & Sons, Inc. Steroidal [16α,17-d]isoxazolidines
DE3133631A1 (de) * 1981-08-21 1983-03-03 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue kortikoide ihre herstellung und verwendung
US5200518A (en) * 1991-02-21 1993-04-06 Kangweon National University Anti-inflammatory carboxycyclic acetal pregnane derivatives
JP2749778B2 (ja) * 1994-09-05 1998-05-13 日清食品株式会社 トリアムシノロン誘導体
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
GB0415747D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
CA2612364A1 (en) * 2005-06-14 2006-12-28 Corus Pharma, Inc. Substituted phenylphosphates as mutual prodrugs of steroids and .beta.-agonists the treatment of pulmonary inflammation and bronchoconstriction
US8524697B2 (en) * 2007-12-21 2013-09-03 Merck Sharp & Dohme Corp. C20-C21 substituted glucocorticoid receptor agonists
JP2011513303A (ja) * 2008-02-27 2011-04-28 アストラゼネカ・アクチエボラーグ １６アルファ，１７アルファ−アセタールグルココルチコステロイド誘導体およびその使用
SG10201608490VA (en) * 2009-09-11 2016-11-29 Chiesi Farma Spa Isoxazolidine derivatives

Also Published As

Publication number Publication date
US20110065678A1 (en) 2011-03-17
UA108858C2 (xx) 2015-06-25
KR101451486B1 (ko) 2014-10-22
HK1166085A1 (zh) 2012-10-19
EA201290091A1 (ru) 2012-12-28
MA33561B1 (fr) 2012-09-01
JP2013504524A (ja) 2013-02-07
CN105175479B (zh) 2017-06-09
WO2011029547A2 (en) 2011-03-17
IL218539A0 (en) 2012-05-31
KR20120055651A (ko) 2012-05-31
BR112012005503A2 (pt) 2016-04-19
TW201114776A (en) 2011-05-01
MY164842A (en) 2018-01-30
US8637662B2 (en) 2014-01-28
CA2773594C (en) 2018-09-25
AU2010294598A1 (en) 2012-04-05
CN102482318B (zh) 2015-11-25
EP2475676B1 (en) 2020-05-27
MX2012002967A (es) 2012-04-30
EA025191B1 (ru) 2016-11-30
AR078164A1 (es) 2011-10-19
CL2012000450A1 (es) 2012-08-10
JO3760B1 (ar) 2021-01-31
AR118123A2 (es) 2021-09-22
EP2475676A2 (en) 2012-07-18
TN2012000077A1 (en) 2013-09-19
EP2993178A1 (en) 2016-03-09
GEP20146135B (en) 2014-08-11
BR112012005503B1 (pt) 2021-10-13
ME01331B (me) 2013-12-20
ZA201201705B (en) 2013-05-29
PE20120894A1 (es) 2012-08-13
CN102482318A (zh) 2012-05-30
SG179055A1 (en) 2012-04-27
CA2773594A1 (en) 2011-03-17
NZ598662A (en) 2014-03-28
WO2011029547A3 (en) 2011-08-18
TWI494318B (zh) 2015-08-01
WO2011029547A8 (en) 2011-06-16
IL218539A (en) 2015-09-24
CO6511204A2 (es) 2012-08-31
AU2010294598B2 (en) 2016-09-01
SG10201608490VA (en) 2016-11-29
CN105175479A (zh) 2015-12-23

Similar Documents

Publication Publication Date Title
ZA201303603B (en) Oxazine derivative
HK1173142A1 (zh) -磺酰基- -氟代嘧啶酮衍生物
HK1172893A1 (zh) -氟嘧啶酮衍生物
ZA201203205B (en) Benzimidazole-imidazole derivatives
IL216007A0 (en) Isoxazole-pyridine derivatives
HK1166085A1 (zh) 異噁唑烷衍生物
ZA201106855B (en) Oxasiazole derivatives
IL215109A0 (en) Isoxazole-pyridazine derivatives
IL214941A0 (en) Isoxazole-pyrazole derivatives
ZA201104991B (en) Deoxyactagardine derivatives
HK1172894A1 (zh) -酰基- -氟嘧啶酮衍生物
HK1169623A1 (zh) 吡嗪並氮雜氧雜環庚烷衍生物
IL214251A0 (en) Isoxazole derivatives
EP2512482A4 (en) DERIVATIVES OF 2-ALDOXIMINO-5-FLUOROPYRIMIDINE
ZA201104279B (en) Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230907